Home » Topics » BioWorld Science

BioWorld Science
RSS

Scios licenses BNP technology to Abbott

June 4, 1997

NeoTherapeutics reports AIT-082 interim phase I/II results

June 3, 1997

RCT issued U.S. patent for azonafide compounds

June 3, 1997

Neurobiological Technologies' Xerecept shows antiedema activity

June 3, 1997

Receptagen receives notice of allowance of U.S. patent for "growth blocker" technology

June 3, 1997

Pharmacokinetics, efficacy and tolerability of reboxetine

June 3, 1997

Alpha Therapeutic and Techniclone report milestone in LYM-1 clinical development

June 3, 1997

Procept completes phase I trial of PRO-2000 gel

June 3, 1997

PPL Therapeutics reports positive phase I results for AAT

June 3, 1997

ACE inhibitors inhibit bone resorption in vitro

June 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...